Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia

• Glavni autori: Cheng-Yi Wang (Autor), Chia-Hung Chen (Autor), Chih-Yen Tu (Autor), Wei-Chih Chen (Autor), Li-Kuo Kuo (Autor), Yao-Tung Wang (Autor), Pin-Kuei Fu (Autor), Shih-Chi Ku (Autor), Wen-Feng Fang (Autor), Chin-Ming Chen (Autor), Chih-Cheng Lai (Autor)
• Format: Knjiga
• Izdano: Elsevier, 2022-09-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Purpose: To compare the clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia (CAP). Patients and methods: We identified patients with severe CAP who received piperacillin-tazobactam based on a nine-center registry database. Further...